FFRct
Device Coronary
PDI 00853341006022
General payments
$6,445,996
Research payments
$3,092,474
Through program year 2025, $6,445,996 in general payments and $3,092,474 in research payments were reported against FFRct (Coronary).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $2,892,904 | 14,152 |
| 2025 | Research | $1,306,475 | 258 |
| 2024 | General | $1,719,876 | 9,587 |
| 2024 | Research | $210,445 | 38 |
| 2023 | General | $1,005,316 | 6,013 |
| 2023 | Research | $548,656 | 54 |
| 2022 | General | $662,179 | 4,019 |
| 2022 | Research | $1,026,898 | 85 |
| 2021 | General | $165,721 | 974 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 101 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
34,745 general · 435 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.